- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 352
GV pushes Envelop VR to $5.5m
Virtual reality software developer Envelop VR has completed a series A round that featured a $1.5m investment by corporate venturing unit GV.
Jan 19, 2016MindTouch reaches out to SAP in $12m round
SAP was among the participants as customer engagement technology developer MindTouch raised $12m in series A capital, 11 years after it was founded.
Jan 19, 2016Tmunity sells Eli Lilly on $10m series A
The pharmaceutical firm's Lilly Asia Ventures unit is co-investing in the T-cell technology developer with University of Pennsylvania.
Jan 19, 2016Neura recognises corporates for $11m series A
The SingTel-backed internet-of-things intelligence technology developer secured the funding in a round featuring Lenovo and AXA.
Jan 19, 2016PierianDx sequences $9.25m series A
The DNA sequencing technology developer raises $9.25m from Utah University's Arup Laboratories and others to further develop its product and increase sales and marketing.
Jan 19, 2016Jerry Education studies for $40m series A
A fund co-created by Shanghai Jiao Ton University's investment unit backs Jerry Education's $40m round to open more schools and develop an online platform.
Jan 19, 2016Intel helps relay $15m to Savioke
Intel Capital has led a series A round for the robot developer, which previously obtained seed funding from backers including Alphabet.
Jan 19, 2016Salesforce hunts down FinanceFox for $5.5m round
FinanceFox reportedly built its mobile insurance management platform on the Salesforce platform, and has now raised cash in a round led by Salesforce Ventures.
Jan 18, 2016Tmunity sells Eli Lilly on $10m series A
The pharmaceutical firm's Lilly Asia Ventures unit is co-investing in the T-cell technology developer with University of Pennsylvania.
Jan 18, 2016Lodo loads up series A with $17m
Lodo Therapeutics has been launched by investment firm Accelerator Corporation with series A capital from investors including AbbVie, Eli Lilly, Wuxi PharmaTech, Pfizer, IBM and Johnson & Johnson.
Jan 18, 2016About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


